OBJECTIVE: This study aimed to explore the association between body mass index (BMI) and mortality based on the 10-year population-based multicenter prospective study. METHODS: A general population-based multicenter prospective study was conducted at four sites in rural China between 2013 and 2023. Multivariate Cox proportional hazards models and restricted cubic spline analyses were used to assess the association between BMI and mortality. Stratified analyses were performed based on the individual characteristics of the participants. RESULTS: Overall, 19,107 participants with a sum of 163,095 person-years were included and 1,910 participants died. The underweight (< 18.5 kg/m ²) presented an increase in all-cause mortality (adjusted hazards ratio [ aHR] = 2.00, 95% confidence interval [ CI]: 1.66-2.41), while overweight (≥ 24.0 to < 28.0 kg/m ²) and obesity (≥ 28.0 kg/m ²) presented a decrease with an aHR of 0.61 (95% CI: 0.52-0.73) and 0.51 (95% CI: 0.37-0.70), respectively. Overweight ( aHR = 0.76, 95% CI: 0.67-0.86) and mild obesity ( aHR = 0.72, 95% CI: 0.59-0.87) had a positive impact on mortality in people older than 60 years. All-cause mortality decreased rapidly until reaching a BMI of 25.7 kg/m ² ( aHR = 0.95, 95% CI: 0.92-0.98) and increased slightly above that value, indicating a U-shaped association. The beneficial impact of being overweight on mortality was robust in most subgroups and sensitivity analyses. CONCLUSION This study provides additional evidence that overweight and mild obesity may be inversely related to the risk of death in individuals older than 60 years. Therefore, it is essential to consider age differences when formulating health and weight management strategies.
Humans ; Body Mass Index ; China/epidemiology* ; Male ; Female ; Middle Aged ; Prospective Studies ; Rural Population/statistics & numerical data* ; Aged ; Follow-Up Studies ; Adult ; Mortality ; Cause of Death ; Obesity/mortality* ; Overweight/mortality*

Objective:To systematically evaluate the incidence of low back pain (LBP) and analyze its main influencing factors among automobile manufacturing workers in China.Methods:In March 2024, literatures related to LBP of workers in the automotive manufacturing industry were retrieved from China National Knowledge Infrastructure (CNKI) , VIP China Science and Technology Journal Database, Wanfang Database, PubMed, and Web of Science Database. The search time range was from the establishment of the database to March 2024, and the literature was screened according to the inclusion and exclusion criteria. After evaluating the quality of the article using the quality evaluation criteria recommended by the Agency for Healthcare Research and Quality in the United States, Stata 17.0 software was used for analysis. Random effects models or fixed effects models were selected based on the degree of heterogeneity to calculate the combined effect size, and subgroup analysis and analysis of influencing factors of LBP were conducted.Results:A total of 16 articles were included, with a total sample size of 22245 people. The literature quality score ranged from 6 to 8 points. The results of the Meta-analysis showed that the incidence of LBP among automobile manufacturing workers in China was 32% (95% CI: 22%, 42%) . The results of subgroup analysis showed that the incidence of LBP among automotive manufacturing workers aged ≥30 years was 39% (95% CI: 22%, 57%) , which was higher than that among automotive manufacturing workers aged <30 years (24%, 95% CI: 17%, 32%) . The incidence of LBP among automotive manufacturing workers with a length of service of ≥5 years was 40% (95% CI: 23%, 56%) , which was higher than that among automotive manufacturing workers with a length of service of <5 years (24%, 95% CI: 16%, 33%) . The incidence of LBP reported from 2011 to 2017 (39%, 95% CI: 18%, 60%) was higher than that from 2018 to 2023 (28%, 95% CI: 20%, 36%) . Working in an uncomfortable posture ( OR=3.72, 95% CI: 2.05, 6.77) , standing for a long time while working ( OR=1.97, 95% CI: 1.61, 2.42) , carrying heavy objects ( OR=1.93, 95% CI: 1.63, 2.30) , bending over while working ( OR=1.86, 95% CI: 1.60, 2.17) and frequent overtime work ( OR=2.38, 95% CI: 1.44, 3.92) were both risk factors for LBP among workers in the automotive manufacturing industry ( P<0.05) , while sufficient rest time ( OR=0.55, 95% CI: 0.48, 0.63) was a protective factor ( P<0.05) . Conclusion:The incidence of LBP among workers in China's automotive manufacturing industry is relatively high. Working in an uncomfortable posture, standing for a long time, carrying heavy objects, bending over for work, frequent overtime work and sufficient rest time are the influencing factors of LBP among workers in the automotive manufacturing industry. Preventive measures should be actively taken in response to the above influencing factors to effectively reduce the incidence of LBP among workers in China's automotive manufacturing industry.

Aim To investigate the therapeutic effects of corylifol A(CYA)on Lewis lung carcinoma(LLC)cachexia mice and its ameliorating effects on myotube atrophy induced by LLC cell-conditioned medium(LLC CM)in vitro,and to explore the mechanisms.Methods The cancer cachexia was induced by subcu-taneous inoculation of LLC cells to C57BL/6J mice.The effects of CYA(10,20 mg·kg-1·d-1,i.p.)on the cachexia symptoms and survival time of cachexia mice were observed.The effects of 2.5 or 5 μmol·L-1 CYA on myotube atrophy of C2C12 induced by LLC CM were observed.The effects of CYA on its pos-sible target the serine/threonine-protein kinase TAO1(TAOK1)and downstream signaling pathways were detected using Western blot.The influence of TAOK1 knockout on the ameliorating effects of CYA on myo-tube atrophy was observed.Results CYA could sig-nificantly prolong the survival time of tumor-bearing mice and ameliorate the muscle atrophy associated with LLC.The effects of CYA on myotube atrophy are relat-ed to its regulation of TAOK1.The effects of CYA could be reduced by knockout of TAOK1.Conclusions CYA improves the survival of LLC cachexia mice and ameliorates the related skeletal muscle atrophy.The mechanism of CYA is related to its inhibition on TAOK1 and downstream signaling pathways.

Objective:To systematically evaluate the incidence of low back pain (LBP) and analyze its main influencing factors among automobile manufacturing workers in China.Methods:In March 2024, literatures related to LBP of workers in the automotive manufacturing industry were retrieved from China National Knowledge Infrastructure (CNKI) , VIP China Science and Technology Journal Database, Wanfang Database, PubMed, and Web of Science Database. The search time range was from the establishment of the database to March 2024, and the literature was screened according to the inclusion and exclusion criteria. After evaluating the quality of the article using the quality evaluation criteria recommended by the Agency for Healthcare Research and Quality in the United States, Stata 17.0 software was used for analysis. Random effects models or fixed effects models were selected based on the degree of heterogeneity to calculate the combined effect size, and subgroup analysis and analysis of influencing factors of LBP were conducted.Results:A total of 16 articles were included, with a total sample size of 22245 people. The literature quality score ranged from 6 to 8 points. The results of the Meta-analysis showed that the incidence of LBP among automobile manufacturing workers in China was 32% (95% CI: 22%, 42%) . The results of subgroup analysis showed that the incidence of LBP among automotive manufacturing workers aged ≥30 years was 39% (95% CI: 22%, 57%) , which was higher than that among automotive manufacturing workers aged <30 years (24%, 95% CI: 17%, 32%) . The incidence of LBP among automotive manufacturing workers with a length of service of ≥5 years was 40% (95% CI: 23%, 56%) , which was higher than that among automotive manufacturing workers with a length of service of <5 years (24%, 95% CI: 16%, 33%) . The incidence of LBP reported from 2011 to 2017 (39%, 95% CI: 18%, 60%) was higher than that from 2018 to 2023 (28%, 95% CI: 20%, 36%) . Working in an uncomfortable posture ( OR=3.72, 95% CI: 2.05, 6.77) , standing for a long time while working ( OR=1.97, 95% CI: 1.61, 2.42) , carrying heavy objects ( OR=1.93, 95% CI: 1.63, 2.30) , bending over while working ( OR=1.86, 95% CI: 1.60, 2.17) and frequent overtime work ( OR=2.38, 95% CI: 1.44, 3.92) were both risk factors for LBP among workers in the automotive manufacturing industry ( P<0.05) , while sufficient rest time ( OR=0.55, 95% CI: 0.48, 0.63) was a protective factor ( P<0.05) . Conclusion:The incidence of LBP among workers in China's automotive manufacturing industry is relatively high. Working in an uncomfortable posture, standing for a long time, carrying heavy objects, bending over for work, frequent overtime work and sufficient rest time are the influencing factors of LBP among workers in the automotive manufacturing industry. Preventive measures should be actively taken in response to the above influencing factors to effectively reduce the incidence of LBP among workers in China's automotive manufacturing industry.

Aim To investigate the therapeutic effects of corylifol A(CYA)on Lewis lung carcinoma(LLC)cachexia mice and its ameliorating effects on myotube atrophy induced by LLC cell-conditioned medium(LLC CM)in vitro,and to explore the mechanisms.Methods The cancer cachexia was induced by subcu-taneous inoculation of LLC cells to C57BL/6J mice.The effects of CYA(10,20 mg·kg-1·d-1,i.p.)on the cachexia symptoms and survival time of cachexia mice were observed.The effects of 2.5 or 5 μmol·L-1 CYA on myotube atrophy of C2C12 induced by LLC CM were observed.The effects of CYA on its pos-sible target the serine/threonine-protein kinase TAO1(TAOK1)and downstream signaling pathways were detected using Western blot.The influence of TAOK1 knockout on the ameliorating effects of CYA on myo-tube atrophy was observed.Results CYA could sig-nificantly prolong the survival time of tumor-bearing mice and ameliorate the muscle atrophy associated with LLC.The effects of CYA on myotube atrophy are relat-ed to its regulation of TAOK1.The effects of CYA could be reduced by knockout of TAOK1.Conclusions CYA improves the survival of LLC cachexia mice and ameliorates the related skeletal muscle atrophy.The mechanism of CYA is related to its inhibition on TAOK1 and downstream signaling pathways.

Sophoridine is a quinolizidine alkaloid extracted from Sophora in legumes, which is one of the main active ingredients of Sophora alopecuroides L, Sophora flavescentis Ait and Sophora davidii (Franch.) skeels. Its molecular formula is C

Objective To understand the distribution and changes in antimicrobial resistance of clinically isolated Pseudomonas aeruginosa(P.aeruginosa)in the member hospitals of Hunan Provincial Antimicrobial Resistance Surveillance System from 2012 to 2021.Methods Antimicrobial susceptibility testing by disk diffusion or automa-ted instrument was performed on clinical isolates.Testing results were determined according to the standards of 2022 edition from American Clinical Laboratory Standards Institute(CLSI).Statistical analysis was performed by WHONET 5.6 software.Data were analyzed by trend test(Cochran-armitage)and Chi-square test with SPSS.Results A total of 176 441 strains of P.aeruginosa were surveilled by Hunan Provincial Antimicrobial Resistance Surveillance System from 2012 to 2021.99.4％of the strains were isolated from hospitalized patients,and about 70％of the strains were isolated from respiratory specimens.8.4％of P.aeruginosa were from children(0-17 years old),91.6％were from adults.Antimicrobial susceptibility testing results showed that P.aeruginosa was most sensitive to polymyxin B over 10 years,with a resis-tance rate of less than 6％.Resistance rates to piperacil-lin,piperacillin/tazobactam,ceftazidime,cefepime,aztreonam,imipenem,amikacin,gentamicin,tobramycin,cip-rofloxacin,levofloxacin,and polymyxin B all showed downward trends.A total of 29 920 carbapenem-resistant P.aeruginosa(CRPA)strains were detected.The average isolation rate of CRPA in this province was 18.0％over 10 years.CRPA detection rate from adult was 18.5％,higher than that from children(12.3％),and both showing downward trends.Conclusion The resistance rate of clinically isolated P.aeruginosa in Hunan Province to most commonly used antimicrobial agents is decreasing.

OBJECTIVE: To investigate the effects of compatibility of Gardeniae Fructus and Rhododendri Mollis Flos on the pharmacokinetic behavior of rhodojaponin II and rhodojaponin III of Rhododendri Mollis Flos. METHODS LC-MS/MS of rhodojaponin II and rhodojaponin III in plasma of rats was developed. The method was then applied to study the blood concentrations of rhodojaponin II and rhodojaponin III in rats after oral compatibility administration of Gardeniae Fructus and Rhododendri Mollis Flos and single decoction administration of Rhododendri Mollis Flos, respectively, then their pharmacokinetic parameters were calculated and statistical analysed. RESULTS: The calibration curve was good linearity(r>0.999) in the range of 1-200 ng·mL-1 for rhodojaponin II and 1-100 ng·mL-1 for rhodojaponin III, the precision of quality control samples was less than 12% and the accuracy was less than 20%. After administration of compatibility of Gardeniae Fructus and Rhododendri Mollis Flos and Rhododendri Mollis Flos alone, the AUC0-t of rhodojaponin II in vivo was(260.44±51.67) and (213.39±59.03)h·ng·mL-1, respectively, and the AUC0-t of rhodojaponin III was (60.97±22.78) and (22.38±5.55)h·ng·mL-1, respectively. Compared with single decoction of Rhododendri Mollis Flos administration group, the T1/2 and MRT(0-t)of the rhodojaponin II were significantly increased, the AUC0-t, T1/2, Tmax and CL of the rhodojaponin III were also significantly rised after administration of compatibility of Gardeniae Fructus and Rhododendri Mollis Flos. CONCLUSION After the compatibility of Gardeniae Fructus and Rhododendri Mollis Flos, the rate of absorption and the distribution volume are increased of rhodojaponin III in rats, while the elimination rate has decreased, the T1/2 of rhodojaponin II and rhodojaponin III are extended, but don't affect the absorption rate of rhodojaponin II in rats.

Background::As a non-invasive and effective diagnostic method for small intestinal bacterial overgrowth (SIBO), wild-use of breath test (BT) has demonstrated a high comorbidity rate in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) and SIBO. Patients overlapping with SIBO respond better to rifaximin therapy than those with IBS-D only. Gut microbiota plays a critical role in both of these two diseases. We aimed to determine the microbial difference between IBS-D overlapping with/without SIBO, and to study the underlying mechanism of its sensitivity to rifaximin.Methods::Patients with IBS-D were categorized as BT-negative (IBSN) and BT-positive (IBSP). Healthy volunteers (BT-negative) were enrolled as healthy control. The patients were clinically evaluated before and after rifaximin treatment (0.4 g bid, 4 weeks). Blood, intestine, and stool samples were collected for cytokine assessment and gut microbial analyses.Results::Clinical complaints and microbial abundance were significantly higher in IBSP than in IBSN. In contrast, severe systemic inflammation and more active bacterial invasion function that were associated with enrichment of opportunistic pathogens were seen in IBSN. The symptoms of IBSP patients were relieved in different degrees after therapy, but the symptoms of IBSN rarely changed. We also found that the presence of IBSN-enriched genera ( Enterobacter and Enterococcus) are unaffected by rifaximin therapy. Conclusions::IBS-D patients overlapping with SIBO showed noticeably different fecal microbial composition and function compared with IBS-D only. The better response to rifaximin in those comorbid patients might associate with their different gut microbiota, which suggests that BT is necessary before IBS-D diagnosis and use of rifaximin.Registration::Chinese Clinical Trial Registry, ChiCTR1800017911.

OBJECTIVE: To evaluate the clinical effect of haploid allogeneic hematopoietic stem cell transplantation(haplo-HSCT) in the treatment of severe aplastic anemia (SAA), and to explore the efficacy different between post-transplant cyclophosphamide (PT/Cy) and standard-dose ATG. METHODS: The clinical data of 38 patients with SAA in our hospital from January 2012 to December 2019 were collected and retrospectively analyzed. The efficacy was evaluated. The patients with haplo-HSCT were divided into low-dose ATG combined with PT/Cy group and standard-dose ATG group, and the blood cell hematopoietic reconstruction time, GVHD incidence, mortality and survival time of the patients in the two groups was compared. RESULTS: Among the 32 patients, hematopoietic reconstitution were detected in 9375%(30/32) recipients. The median time of neutrophil and platelet engraftment was 15(10-22) days and 13(7-30) days, respectively. The incidence of GVHD was 21.89%, the incidence of infection was 93.75%, and the 2-year overall survival rate was 84.38%. The hematopoietic reconstitution time, incidence of GVHD, mortality rate and survival time were no statistical differences between the patients in the two groups(all P>0.05). CONCLUSION Haplo-HSCT is an effective method for the treatment of SAA，low-dose ATG combined with PT/Cy can lighten the economic burden on patients, it would be a feasible treatment plan for SAA with light side effect.
Anemia, Aplastic/therapy* ; Cyclophosphamide ; Graft vs Host Disease ; Haploidy ; Hematopoietic Stem Cell Transplantation ; Humans ; Retrospective Studies ; Transplantation Conditioning